Company intelligence / Profile preview

Living Goods

Nairobi, Kenya

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Living Goods demonstrated a 28-30% reduction in under-5 child mortality and 27% reduction in neonatal mortality in randomized controlled trials in Uganda (preliminary, 2021)

Therapeutic areas: Women's HealthGastroenterologyInfectious DiseasesMetabolic DisordersOther
Modalities: Non-pharmacological therapyDeviceSmall moleculeVaccine
Industry: Non-Academic Healthcare

Partnerships

Medic Mobile (technology)Jhpiego (health program partner)Ministries of Health (Kenya, Uganda, Burkina Faso)LGT Venture Philanthropy

Beyond the preview

Go deeper on Living Goods.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Living Goods.

Explore the full profile